Cutaneous graft-versus-host disease (GVHD) can be a long-term complication of stem cell transplantation that requires careful management. Speaking from the European Group for Blood and Marrow Transplantation (EBMT) 2018 Annual Meeting, held in Lisbon, Portugal, Jacqui Stringer, PhD, BSc, RGN, MIFPA, Chairperson of the European Group for Blood and Marrow Transplantation (EBMT) Nurses Group Research Committee, of the Christie NHS Foundation Trust, Manchester, UK, passionately discusses the importance of the nurse in managing this condition.